Predictors of HVTN 503 MRK AD5 HIV-1 Gag/Pol/Nef Vaccine-Induced Immune Response

被引：0
|
作者：
Cerwensky, K. [1 ]
Laher, F. [1 ]
Otwombe, K. [1 ]
Churchyard, G. [2 ]
Bekker, L. [3 ]
Nchabeleng, M. [4 ]
Mlisana, K. [5 ]
Kublin, J. [6 ]
Gray, G. [1 ]
机构：
[1] Univ Witwatersrand, Soweto, South Africa
[2] Aurum Inst Hlth Res, Johannesburg, South Africa
[3] Univ Cape Town, ZA-7925 Cape Town, South Africa
[4] Univ Limpopo, Limpopo, South Africa
[5] Univ KwaZulu Natal, CAPRISA, Kwa Zulu, South Africa
[6] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2013年 / 29卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A88 / A88
页数：1
相关论文
共 50 条
  • [41] Phase I trial of a prophylactic HIV-1 gag-pol-env DNA plasmid vaccine with IL-12 or IL-15 DNA molecular adjuvants (HVTN 070)
    Parker, S.
    Elizaga, M.
    Kim, D.
    Metch, B.
    Allen, M.
    De Rosa, S.
    Hural, J.
    Torres, K.
    Boyer, J.
    Joseph, P.
    Weiner, D. B.
    Kalams, S.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A91 - A91
  • [42] A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial
    Hertz, T.
    Logan, M. G.
    Rolland, M.
    Magaret, C. A.
    Rademeyer, C.
    Fiore-Gartland, A.
    Edlefsen, P. T.
    DeCamp, A.
    Ahmed, H.
    Ngandu, N.
    Larsen, B. B.
    Frahm, N.
    Marais, J.
    Thebus, R.
    Geraghty, D.
    Hural, J.
    Corey, L.
    Kublin, J.
    Gray, G.
    McElrath, M. J.
    Mullins, J. I.
    Gilbert, P. B.
    Williamson, C.
    VACCINE, 2016, 34 (47) : 5792 - 5801
  • [43] Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens
    Huang, Yunda
    Zhang, Yuanyuan
    Seaton, Kelly E.
    De Rosa, Stephen
    Heptinstall, Jack
    Carpp, Lindsay N.
    Randhawa, April Kaur
    McKinnon, Lyle R.
    McLaren, Paul
    Viegas, Edna
    Gray, Glenda E.
    Churchyard, Gavin
    Buchbinder, Susan P.
    Edupuganti, Srilatha
    Bekker, Linda-Gail
    Keefer, Michael C.
    Hosseinipour, Mina C.
    Goepfert, Paul A.
    Cohen, Kristen W.
    Williamson, Brian D.
    McElrath, M. Juliana
    Tomaras, Georgia D.
    Thakar, Juilee
    Kobie, James J.
    EBIOMEDICINE, 2022, 84
  • [44] A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults
    Omosa-Manyonyi, Gloria
    Mpendo, Juliet
    Ruzagira, Eugene
    Kilembe, William
    Chomba, Elwyn
    Roman, Francois
    Bourguignon, Patricia
    Koutsoukos, Marguerite
    Collard, Alix
    Voss, Gerald
    Laufer, Dagna
    Stevens, Gwynn
    Hayes, Peter
    Clark, Lorna
    Cormier, Emmanuel
    Dally, Len
    Barin, Burc
    Ackland, Jim
    Syvertsen, Kristen
    Zachariah, Devika
    Anas, Kamaal
    Sayeed, Eddy
    Lombardo, Angela
    Gilmour, Jill
    Cox, Josephine
    Fast, Patricia
    Priddy, Frances
    PLOS ONE, 2015, 10 (05):
  • [45] HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection:: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates
    Heeney, J
    Åkerblom, L
    Barnett, S
    Bogers, W
    Davis, D
    Fuller, D
    Koopman, G
    Lehner, T
    Mooij, P
    Morein, B
    Morghen, CD
    Rosenwirth, B
    Verschoor, E
    Wagner, R
    Wolf, H
    IMMUNOLOGY LETTERS, 1999, 66 (1-3) : 189 - 195
  • [46] Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection
    Betts, MR
    Exley, B
    Price, DA
    Bansal, A
    Camacho, ZT
    Teaberry, V
    West, SM
    Ambrozak, DR
    Tomaras, G
    Roederer, M
    Kilby, JM
    Tartaglia, J
    Belshe, R
    Gao, F
    Douek, DC
    Weinhold, KJ
    Koup, RA
    Goepfert, P
    Ferrari, G
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (12) : 4512 - 4517
  • [47] HIV-1 p24gag Derived Conserved Element DNA Vaccine Increases the Breadth of Immune Response in Mice
    Kulkarni, Viraj
    Rosati, Margherita
    Valentin, Antonio
    Ganneru, Brunda
    Singh, Ashish K.
    Yan, Jian
    Rolland, Morgane
    Alicea, Candido
    Beach, Rachel Kelly
    Zhang, Gen-Mu
    Le Gall, Sylvie
    Broderick, Kate E.
    Sardesai, Niranjan Y.
    Heckerman, David
    Mothe, Beatriz
    Brander, Christian
    Weiner, David B.
    Mullins, James I.
    Pavlakis, George N.
    Felber, Barbara K.
    PLOS ONE, 2013, 8 (03):
  • [48] Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans
    Pine, Samuel O.
    Kublin, James G.
    Hammer, Scott M.
    Borgerding, Joleen
    Huang, Yunda
    Casimiro, Danilo R.
    McElrath, M. Juliana
    PLOS ONE, 2011, 6 (04):
  • [49] IMMUNE-RESPONSE TO HIV-1 GAG ANTIGENS INDUCED BY RECOMBINANT ADENOVIRUS VECTORS IN MICE AND RHESUS MACAQUE MONKEYS
    PREVEC, L
    CHRISTIE, BS
    LAURIE, KE
    BAILEY, MMS
    GRAHAM, FL
    ROSENTHAL, KL
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (06): : 568 - 576
  • [50] ENHANCEMENT OF CELL-MEDIATED IMMUNE RESPONSE IN MICE BY WHOLE HIV-1 GAG IN MYCOBACTERIUM BOVIS BCG AS A LIVE VACCINE CANDIDATE
    Promkhatkaew, Duanthanorm
    Pinyosukhee, Nadthanan
    Thongdeejaroen, Wilai
    Sutthent, Reungpung
    Sawanpanyalert, Pathom
    Warachit, Paijit
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2009, 40 (01) : 113 - 122
12345